Skip to content

Dr. Sengeleng Jan

Active Private limited companyfounded 2008active for 18 yearsSint-Annastraat 165, 9220 Hamme (Vl.)KBO/BCE: BE 0898.825.655

Lifetime

18 annual accounts with figures on one time axis
peak of €146,477 in 2023
€135,361▼ 7.2%
lowest -€11,229 in 2010
€108,829▼ 13.3%
peak of €506,244 in 2024
€435,137▼ 14.0%
€22,362▲ 20.7%
Board1 name since 2008
1 director
Documentsfilings and deeds
18-05-202674 days before the deadline
2025micro format
Dividend €179,936Equity from €506,244 to €435,137Debts from €18,525 to €22,362

Key points

from the 2025 annual accounts

Equity

€435,137 ▼ 14.0%
506,2442024+108,829Profit-179,936Dividend435,1372025

Dr. Sengeleng Jan paid out €179,936 in dividends. That is 165% of the 2025 profit.

Filings

18 annual accounts since 2008
AprilJune31 JulyOctober2010201520202025

The last five annual accounts were filed 70 to 99 days before the end of the period.

Position in the sector

95.1%

Higher solvency than 91% of companies in human health. The sector median is 63.1%, over 21,373 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,817 companies had the same profile as Dr. Sengeleng Jan has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,817 companies, not a prediction for Dr. Sengeleng Jan. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 23-06-2008
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0898825655
changes role from manager to director General meeting of 04-07-2022 · Gazette deed
Capital decrease of €74,400 to €18,600 The capital fell from €93,000 to €18,600 · General meeting of 28-08-2014 · Gazette deed
Registered office moved within Hamme The registered office moved from Sint-Anna 82, 9220 Hamme to Sint-Annastraat 165 9220 HAMME · Gazette deed
All 36 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Sengeleng Jan Hamme (Vl.) €457,498 €135,361 95.1% -
DR. KATHLEEN VERMEULEN Deinze €470,187 €131,895 97.4% -
Dokter Hilde Verhaegen Aalter €518,641 €133,609 47.9% -
DR.JAN VAN BEVEREN Sint-Niklaas €440,137 €149,125 81.2% -
DR. BERGEZ JACQUES, HUISARTS Aalter €412,357 €136,540 91.9% -
HUISARTSENPRAKTIJK COLLA EN VERMARIEN Dilsen-Stokkem €436,786 €133,792 86.6% -
DOKTER STAS AN, ALGEMENE GENEESKUNDE Sint-Pieters-Leeuw €426,545 €131,919 89.9% -

These companies have the same main activity as Dr. Sengeleng Jan: general medical practice (NACE 86210). They are comparable in size and age: total assets between €412,000 and €519,000, founded between 2006 and 2011.

Official details

Source: KBO
Status
Active since 26-06-2008Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.185.870.1559220 Hamme (Vl.), since 23-06-2008
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Annual accounts 2025

≈ €240,000estimated
€457,498▼ 12.8%
Filing
Filed on 18-05-2026, 74 days before the end of the filing period
Financials

Insights on Dr. Sengeleng Jan

Dr. Sengeleng Jan files the micro format. That format states no turnover. The gross margin rose from €52,334 in 2008 to €135,361 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Sengeleng Jan

What is the company number of Dr. Sengeleng Jan?
The company number of Dr. Sengeleng Jan is 0898.825.655. The VAT number is the same number with BE in front: BE 0898.825.655.
Where is Dr. Sengeleng Jan based?
The registered office is at Sint-Annastraat 165, 9220 Hamme (Vl.).Company details
What does Dr. Sengeleng Jan do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Sengeleng Jan?
Dr. Sengeleng Jan is a private limited company (BV).
When was Dr. Sengeleng Jan founded?
Dr. Sengeleng Jan was founded on 26-06-2008.
Is Dr. Sengeleng Jan still active?
Yes, Dr. Sengeleng Jan is an active enterprise in the KBO register.
What is the turnover of Dr. Sengeleng Jan?
The turnover in financial year 2025 is about €240,000. This figure is estimated from the gross margin of €135,361 and 30 comparable companies (NACE 86210). It probably lies between €200,000 and €310,000.Financials
Is Dr. Sengeleng Jan profitable?
In financial year 2025, Dr. Sengeleng Jan made a profit of €108,829.
Where can I find the annual accounts of Dr. Sengeleng Jan?
Dr. Sengeleng Jan filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Sengeleng Jan due?
Dr. Sengeleng Jan must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.